Medical Condition News

RSS

Aastrom Biosciences treats final patient in IMPACT-DCM Phase 2 surgical clinical trial

Aastrom Biosciences, Inc., a leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported the final patient treatment in the company's ongoing U.S. Phase 2 surgical clinical trial designated IMPACT-DCM.

10 Mar 2010

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

10 Mar 2010

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

Integra LifeSciences Holdings Corporation announced today the release of the Integra™ Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing soft tissue irritation. The system provides an optimal balance of compression and stability by combining the Surfix® locking technology and dynamic compression.

10 Mar 2010

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.

10 Mar 2010

FDA clears Oculus Innovative Sciences' Microcyn Skin and Wound HydroGel

Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.

10 Mar 2010

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

NeoPharm, Inc., announced today that it has filed an orphan drug application with the Office of Orphan Products Development of the United States Food and Drug Administration to have Orphan Drug Designation granted to IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis.

10 Mar 2010

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies’ exclusive global agreement to develop and commercialize Hematide™, Affymax’s investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.

10 Mar 2010

$Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures$

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

10 Mar 2010

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

Smith & Nephew's Endoscopy Division today announced the launch of the BIORAPTOR™ Knotless Suture Anchor, a device used to repair a torn labrum in the hip and shoulder. The anchor is among products featured at the American Academy of Orthopaedic Surgeons annual meeting, which began today in New Orleans.

10 Mar 2010

ESWT applied with SANUWAVE’s Ossatron device results in 80% healing rate of nonunions of the tibia

SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that a journal article titled Extracorporeal Shock Wave Therapy for Nonunion of the Tibia, was published in the March 2010 issue of the Journal of Orthopedic Trauma.

10 Mar 2010

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Abbott announced today it has received U.S. Food and Drug Administration approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.

10 Mar 2010

Reductions in tobacco use and increased screening for early detection reduces cancer death rates

A new American Cancer Society study finds progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The study appears in the open access journal PLos ONE, and finds a downturn in cancer death rates since 1990 results mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers.

10 Mar 2010

Protein competition over MAPK provides mechanism to integrate different signals directing early embryonic development

A Princeton University-led research team has discovered that protein competition over an important enzyme provides a mechanism to integrate different signals that direct early embryonic development. The work suggests that these signals are combined long before they interact with the organism's DNA, as was previously believed, and also may inform new therapeutic strategies to fight cancer.

10 Mar 2010

Spring weather determines severity of allergy symptoms

With record-setting snowfall and wet weather in the region this winter, one question comes to mind for many as spring approaches: how bad will my allergies be?

10 Mar 2010

African-Americans and Hispanics are at higher risk for developing Alzheimer's and dementias

According to the Alzheimer's Association's® 2010 Alzheimer's Disease Facts and Figures, African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer's and other dementias.

10 Mar 2010

Harris Poll: Obesity increased, cigarette smoking decreased in every five-year period

The annual Harris Poll that has measured key health risks – smoking, seat belt use, weight and obesity – for the last 28 years, provides both good and bad news.

10 Mar 2010

Combating DVT and PE: Critical recommendations

Three critical recommendations from a national workshop have been released to address deep-vein thrombosis (DVT) and pulmonary embolism (PE), a growing public health problem estimated to affect nearly 1 million Americans each year.

10 Mar 2010

Young women with heart attacks at higher risk of dying in hospital than men

Geisinger Health System and Yale School of Medicine investigators are researching how young people recover from heart attacks through VIRGO (Variation in Recovery: Role of Gender on Outcomes in Young AMI Patients), a research project funded by the National, Heart, Lung and Blood Institute.

10 Mar 2010

First use of prenatal MRI to detect often-misdiagnosed CCD

In a case believed to be a United States first, the radiology team at Lucile Packard Children's Hospital has used prenatal magnetic resonance imaging to detect an often-misdiagnosed genetic disease.

10 Mar 2010

Team Lung Love: New endurance sports training program focused on raising awareness for lung cancer

Lung Cancer Alliance announced the launch of Team Lung Love (TLL), an endurance sports training program focused exclusively on raising awareness and support for lung cancer.

10 Mar 2010

Medical Condition News

Aastrom Biosciences treats final patient in IMPACT-DCM Phase 2 surgical clinical trial

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Integra LifeSciences releases FDA cleared Total Wrist Fusion System

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

FDA clears Oculus Innovative Sciences' Microcyn Skin and Wound HydroGel

NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF

Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Smith & Nephew introduces BIORAPTOR Knotless Suture Anchor

ESWT applied with SANUWAVE’s Ossatron device results in 80% healing rate of nonunions of the tibia

FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients

Reductions in tobacco use and increased screening for early detection reduces cancer death rates

Protein competition over MAPK provides mechanism to integrate different signals directing early embryonic development

Spring weather determines severity of allergy symptoms

African-Americans and Hispanics are at higher risk for developing Alzheimer's and dementias

Harris Poll: Obesity increased, cigarette smoking decreased in every five-year period

Combating DVT and PE: Critical recommendations

Young women with heart attacks at higher risk of dying in hospital than men

First use of prenatal MRI to detect often-misdiagnosed CCD

Team Lung Love: New endurance sports training program focused on raising awareness for lung cancer

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News